- What are electromagnetic fields?
- Static and low-frequency fields
- What are static and low-frequency fields?
- Reports & Evaluations
- Radiation protection relating to the expansion of the national grid
- Basics transfer of electrical power
- High-frequency fields
- What are high-frequency fields?
- Applications high-frequency fields
- Radiation protection in mobile communication
- What is mobile communication?
- Reports and evaluations
- What is optical radiation?
- UV radiation
- What is UV radiation?
- Sun but safe!
- Effects of UV radiation
- Protection against UV radiation
- UV index
- Infrared radiation
- What is ionising radiation?
- Radioactivity in the environment
- Where does radioactivity occur in the environment?
- What is the level of natural radiation exposure in Germany?
- Air, soil and water
- Building materials
- Industrial residues (NORM)
- BfS laboratories
- Applications in medicine
- Applications in daily life and in technology
- Radioactive radiation sources in Germany
- Register high-level radioactive radiation sources
- Type approval procedure pursuant to RöV and StrlSchV
- Cabin luggage security checks
- Radioactive materials in watches
- Ionisation smoke detectors (ISM)
- What are the effects of radiation?
- Acute radiation damage
- Effects of selected radioactive materials
- Consequences of a radiation accident
- Cancer and leukaemia
- Genetic radiation effects
- Individual radiosensitivity
- Epidemiology of radiation-induced diseases
- Ionising radiation: positive effects?
- Risk estimation and assessment
- Radiation protection
- Basic informations
- Occupational radiation protection
- Nuclear accident management
- What happens in an emergency?
- Federal and state tasks
- In the event of an emergency
- Measuring networks
- Exercises for emergency situations
- Nuclear accidents
- Defence against nuclear hazards
- Service offers
- Radon measurements
- Incorporation monitoring
- Biological dosimetry
- About us
- Science and research
- Research concept
- Scientific collaborations
- EU research framework programme
- BfS research programme
- Third-party funded research
- Departmental research
- Selected research projects
- Selected research results
- Professional opinions
- Laws and regulations
- BfS Topics in the Bundestag
One of the major tasks of the Federal Office for Radiation Protection's (BfS) Coordinating Office on Incorporation Monitoring is to support the approved laboratories for incorporation monitoring (ALfIM) in their quality assurance in all stages in assessing the internal dose. This means that the Coordinating Office has to take special care of the regular performance of intercomparisons in the in-vivo laboratories (whole body and partial body counter) and the in-vitro laboratories (excretion analysis).
These intercomparisons generally consist of two parts:
- a practical part where the laboratories have to determine the activity in a body phantom or the activity concentration in an excretion sample, and
- a theoretical part, the so-called case study, where the internal dose has to be assessed by using monitoring data.
Also German non-governmental laboratories and laboratories from abroad may participate in the interlaboratory comparisons of the Coordinating Office on Incorporation Monitoring of the BfS.
The in-vivo intercomparisons are carried out once a year. They generally include alternatively
- the measurement of the activity of a whole body phantom (replication of a human body) with a homogeneous distribution of given radionuclides and
|Announcement||Beginning of the year|
|Preparation of phantoms|
|Carrying out the measuring campaign||Late summer|
|Deadline for reevaluations||Up to two weeks after the measuring campaign|
|Information about the first evaluations by e-mail||By beginning of the following year|
|Statistic evaluation of the IC||Spring of the following year|
|Possibility of statements by the IC participants|
The in-vitro intercomparisons are carried out once a year as well. They generally include the determination of the activity concentration of given radionuclides in urine (and/or in faeces).
|Announcement||Middle of the year|
|Preparation resp. production of IC samples|
|Forwarding of the samples to the IC participants||Second half of the year|
|IC participants inform about their results||Beginning of the following year|
|Evaluation of IC results|
|Informing IC participants about first results (by e-mail)||First quarter of the following year|
|Carrying out a workshop with the German-speaking IC participants||Middle of the following year|
|Officially informing IC participants about the results including the respective BfS report.||End of the following year|
Realisation of case studies
Additionally to the intercomparisons for quality assurance of laboratories for incorporation monitoring dosimetrical case studies are carried out once a year as well. Also German non-governmental laboratories and laboratories from abroad may participate in the evaluation of case studies of the Coordinating Office on Incorporation Monitoring of the BfS.
In this theoretical part, on the basis of monitoring data the internal dose has to be assessed. This data can be fictitious or can be based on a real case of in-vivo or/and in-vitro monitoring.
The time of the realisation of the case studies is matched with the intercomparisons. Announcement, distribution, and evaluation of the case studies are taking place in the fourth quarter of the running year. The final results including a model answer will be dispatched in the first quarter the following year.
State of 2016.10.07